Abu Dhabi: Two medical products prescribed for the treatment of high blood pressure went off shelves for containing chemical impurities which may cause cancer.
The Ministry of Health and Prevention Assistant Undersecretary for Public Health and Licences Dr Amin Hussein Al-Amiri issued a circular withdrawing ' Arbitense 50 ' and 100mg ' Losartan Potassium ' tablet, which is manufactured by Neopharma.
Dr Al-Amiri has also issued a second circular banning 'Hetlosar 50 ' and 100mg 'Losartan Potassium ' tablet which is produced by Nexgenpharma firm.